Neurocrine Biosciences (NBIX) Interest Coverage Ratio (2017 - 2026)

Neurocrine Biosciences (NBIX) has reported Interest Coverage Ratio for 9 consecutive years, with 52.24 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Interest Coverage Ratio changed N/A year-over-year to 52.24; the trailing twelve-month figure through Jun 2026 stood at 155.84 (up 3.9% YoY), and the FY2023 full-year result was 54.54, up 55.53% from the prior year.
• Interest Coverage Ratio fell to 52.24 in Q2 2026 per NBIX's latest filing, from 90.27 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 136.64 in Q4 2023 and bottomed at 103.82 in Q1 2023.
• Historically, Interest Coverage Ratio has averaged 55.35 across 4 years, with a median of 64.89 in 2023.
• The sharpest annual moves came in 2022 and 2023: Interest Coverage Ratio surged 1809.09% in 2022, then tumbled 8807.33% in 2023.
• Over 4 years, Interest Coverage Ratio stood at 94.0 in 2022, then surged by 45.36% to 136.64 in 2023, then tumbled by 33.93% to 90.27 in 2024, then plunged by 42.13% to 52.24 in 2026.
• According to Business Quant data, Interest Coverage Ratio over the past three periods registered 52.24, 90.27, and 136.64 for Q2 2026, Q1 2024, and Q4 2023 respectively.